Showing results (171-180 of 228) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Investigation|January 1, 1989
Role of invading leukocytes in enhanced atrial eicosanoid production following rabbit left ventricular myocardial infarctionM S Freed, P Needleman, C G Dunkel, et al.
The American Journal of Physiology|February 1, 1986
Effects of atriopeptin infusion versus effects of left atrial stretch in awake dogsK L Goetz, B C Wang, P G Geer, et al.
American Journal of Obstetrics and Gynecology|February 29, 2000
Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2Y Sadovsky, D M Nelson, L J Muglia, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1977
Prostaglandins and the renin-angiotensin system in canine endotoxemiaP C Isakson, F Shofer, R C McKnight, et al.
Prostaglandins|April 1, 1977
Imidazole: a selective inhibitor of thromboxane synthetaseS Moncada, S Bunting, K Mullane, et al.
Gastroenterology|April 30, 1999
Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascitesM Bosch-Marcè, J Clària, E Titos, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenicJ L Masferrer, B S Zweifel, P T Manning, et al.
Circulation Research|May 1, 1989
Mechanisms underlying atriopeptin-induced increases in hematocrit and vascular permeation in ratsJ R Williamson, S W Holmberg, K Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Essential fatty acid deficiency reduces the inflammatory cell invasion in rabbit hydronephrosis resulting in suppression of the exaggerated eicosanoid productionS M Spaethe, M S Freed, K De Schryver-Kecskemeti, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancersA T Koki, N K Khan, B M Woerner, et al.
Pageof 23